Mariam P. Alexander
MD
Professor of Laboratory Medicine & Pathology, Consultant Renal Pathology, Mayo Clinic,
Rochester, MN, USA
(Chair)

Pathology of immune-checkpoint inhibitor therapy
Friday, Sep 13th, 10:00

Renal pathology in monoclonal gammopathy
Friday, Sep 13th, 16:30

Philippe R. Bauer
MD, PhD
Professor of Medicine,
Consultant Pulmonary & Critical Care, Mayo Clinic,
Rochester, MN, USA

ICU management of hemato-oncologic therapy complications
Friday, Sep 13th, 12:40

Critical care of immunocompromised patients
Friday, Sep 13th, 17:30

Jürgen Behr
MD
Professor of Medicine, Director Medical Clinic V - Pulmunology, LMU University Hospital,
LMU Munich

Lung transplantation in patients with pulmonary hypertension
Thursday, Sep 12th, 17:30

Michael von Bergwelt
MD,PhD
Professor of Medicine,
Director Medical Clinic III,
Hematology and Oncology,
LMU University Hospital, LMU Munich (Chair)

Welcome and introduction
Thursday, Sep 12th, 15:30

Wrap up and Farewell
Saturday, Sep 14th, 12:30

Anke von Bergwelt-Baildon
MD

Senior physician at the Nephrology Center,
Medical Clinic IV,
LMU University Hospital,
LMU Munich

Veit Bücklein
MD
Attending Hematologist-Oncologist at the Medical Clinic III
Hematology and Oncology LMU University Hospital,
LMU Munich



CAR-T cell therapy in hemato-oncology
Saturday, Sep 14th, 09:00

Case Session
Saturday, Sep 14th, 11:00

Clemens Cohen
MD
Professor of Medicine,
Head Department for Nephrology, München Klinik gGmbH
(Chair)

Chair: Dealing with Complications of Novel Therapy
Friday, Sep 13th, 14:10

Ali Duarte Garcia
MD
Assistant Professor of Medicine, Consultant Rheumatology, Mayo Clinic,
Rochester, MN, USA


Lupus nephritis – current and future treatment options
Friday, Sep 13th, 14:30

APS reclassified: understanding the new criteria
and the clinical impact
Saturday, Sep 14th, 11:30

Hilary M. DuBrock
MD
Associate Professor of Medicine, Consultant Pulmonary & Critical Care, Mayo Clinic,
Rochester, MN, USA

Pulmonary hypertension associated with myeloproliferative and kidney disease
Thursday, Sep 12th, 16:15

Fernando C. Fervenza
MD,PhD
Professor of Medicine, Consultant Nephrology & Hypertension, Mayo Clinic,
Rochester, MN, USA
(Chair)

Management of membranous nephropathy
Friday, Sep 13th, 09:40

Primary, secondary and genetic forms of FSGS: a clinical approach
Friday, Sep 13th, 15:00

Tobias Feuchtinger
MD
Professor of Medicine, Professor of Medicine, Director Pediatric, Hematology and Oncology,
University Hospital Freiburg

Cell therapy in infectious disease
Saturday, Sep 14th, 10:00

Michael Fischereder
MD
Professor of Medicine, Head of the Nephrology Center, Medical Clinic IV, LMU University Hospital,
LMU Munich (Chair)
(Chair)

Welcome and introduction
Thursday, Sep 12th, 15:30

Wrap up and Farewell
Saturday, Sep 14th, 12:30

Jürgen Floege
MD
Professor of Medicine,
Director emeritus of the Medical Clinic II – Kidney and Hypertension Diseases,
University Hospital of RWTH Aachen

IgA nephropathy – how to treat in the future?
Friday, Sep 13th, 08:30

Louise Füeßl
MD
Medical Clinic IV,
LMU University Hospital,
LMU Munich

Case Session
Friday, Sep 13th, 16:00

Sebastian Kobold
MD
Professor of experimental immune-oncology, Deputy Director of the Department of Clinical Pharmacology, LMU University Hospital, LMU Munich

Immunotherapy of cancer – from bench to bedside
Thursday, Sep 12th, 18:00

Maximilian F. Konig
MD
Assistant Professor of Medicine, Rheumatology, Johns Hopkins University,
Baltimore, MD, USA



Avoiding collateral damage: precision immuno-therapy for autoimmunity and cancer
Friday, Sep 13th, 17:00

Antigen-specific therapies for anti-phospholipid syndrome
Saturday, Sep 14th, 12:00

Andreas Mackensen
MD
Professor of Medicine, Medical Clinic 5, Hematology and internal Oncology, University Hospital Erlangen

CAR-T cell therapy for autoimmune disease
Saturday, Sep 14th, 09:30

Tobias Peikert
MD
Associate Professor of Medicine, Consultant Pulmonary & Critical Care, Mayo Clinic,
Rochester, MN, USA
(Chair)


Lung cancer therapy in the age of immunotherapy
Friday, Sep 13th, 10:40

Immunotherapy for mesothelioma
Friday, Sep 13th, 11:40

Ulf Schönermarck
MD
Senior physician at the Nephrology Center, Medical Clinic IV, LMU University Hospital,
LMU Munich (Chair)

Chair: From bench to bedside
Saturday, Sep 14th, 11:00

Sanjeev Sethi
MD, PhD
Professor of Laboratory Medicine and Pathology, Consultant Renal Pathology, Mayo Clinic,
Rochester, MN, USA
(Chair)

Mapping the antigens of membranous nephropathy
Friday, Sep 13th, 09:00

C3 Glomerulopathy: what is new?
Friday, Sep 13th, 14:10

Ulrich Specks
MD
Professor of Medicine, Consultant Pulmonary & Critical Care, Mayo Clinic, Rochester, MN, USA (Chair)




Welcome and introduction
Thursday, Sep 12th, 15:30

ANCA-associated vasculitis: from pathogenesis to targeted therapy
Thursday, Sep 12th, 15:45

Wrap up and Farewell
Saturday, Sep 14th, 12:30

Christine Spitzweg
MD
Professor of Medicine,
Division of Endocrinology, Medical Clinic IV,
LMU University Hospital,
LMU Munich
(Chair)


Chair: Immunotherapy – from Vision to Standard of Care
Friday, Sep 13th, 10:40

Michael Staehler
MD
Professor of Medicine, Senior Physician at the Urological Clinic and Polyclinic, LMU University Hospital, LMU Munich

Immune-checkpoint inhibitor therapy in renal cell carcinoma
Friday, Sep 13th, 11:10

Volker Vielhauer
MD
Professor of Medicine,
Senior physician at the
Nephrology Center,
Medical Clinic IV,
LMU University Hospital,
LMU Munich

Chair: Novel Classification in Kidney Disease Impacts Management
Friday, Sep 13th, 08:30

Mariam P. Alexander
MD
Professor of Laboratory Medicine & Pathology, Consultant Renal Pathology, Mayo Clinic,
Rochester, MN, USA
(Chair)

Pathology of immune-checkpoint inhibitor therapy
Friday, Sep 13th, 10:00

Renal pathology in monoclonal gammopathy
Friday, Sep 13th, 16:30

Philippe R. Bauer
MD, PhD
Professor of Medicine,
Consultant Pulmonary & Critical Care, Mayo Clinic,
Rochester, MN, USA




ICU management of hemato-oncologic therapy complications
Friday, Sep 13th, 12:40

Critical care of immunocompromised patients
Friday, Sep 13th, 17:30

Jürgen Behr
MD
Professor of Medicine, Director Medical Clinic V - Pulmunology, LMU University Hospital,
LMU Munich

Lung transplantation in patients with pulmonary hypertension
Thursday, Sep 12th, 17:30

Michael von Bergwelt
MD,PhD

Professor of Medicine,
Director Medical Clinic III,
Hematology and Oncology,
LMU University Hospital, LMU Munich (Chair)

Welcome and introduction
Thursday, Sep 12th, 15:30

Wrap up and Farewell
Saturday, Sep 14th, 12:30

Veit Bücklein
MD
Attending Hematologist-Oncologist at the Medical Clinic III
Hematology and Oncology LMU University Hospital,
LMU Munich


CAR-T cell therapy in hemato-oncology
Saturday, Sep 14th, 09:00

Case Session
Saturday, Sep 14th, 11:00

Clemens Cohen
MD
Professor of Medicine,
Head Department for Nephrology, München Klinik gGmbH
(Chair)

Chair:
Dealing with Complications of Novel Therapy
Friday, Sep 13th, 14:10

Ali Duarte Garcia
MD
Assistant Professor of Medicine, Consultant Rheumatology, Mayo Clinic,
Rochester, MN, USA


Lupus nephritis – current and future treatment options
Friday, Sep 13th, 14:30

APS reclassified: understanding the new criteria
and the clinical impact
Saturday, Sep 14th, 11:30

Hilary M. DuBrock
MD

Associate Professor of Medicine, Consultant Pulmonary & Critical Care, Mayo Clinic,
Rochester, MN, USA

Pulmonary hypertension associated with myeloproliferative and kidney disease
Thursday, Sep 12th, 16:15

Fernando C. Fervenza
MD,PhD
Professor of Medicine, Consultant Nephrology & Hypertension, Mayo Clinic,
Rochester, MN, USA
(Chair)

Management of membranous nephropathy
Friday, Sep 13th, 09:40

Primary, secondary and genetic forms of FSGS: a clinical approach
Friday, Sep 13th, 15:00

Tobias Feuchtinger
MD
Professor of Medicine, Professor of Medicine, Director Pediatric, Hematology and Oncology,
University Hospital Freiburg

Cell therapy in infectious disease
Saturday, Sep 14th, 10:00

Michael Fischereder
MD
Professor of Medicine, Head of the Nephrology Center, Medical Clinic IV, LMU University Hospital,
LMU Munich (Chair)
(Chair)

Welcome and introduction
Thursday, Sep 12th, 15:30

Wrap up and Farewell
Saturday, Sep 14th, 12:30

Jürgen Floege
MD
Professor of Medicine,
Director emeritus of the Medical Clinic II – Kidney and Hypertension Diseases,
University Hospital of RWTH Aachen

IgA nephropathy – how to treat in the future?
Friday, Sep 13th, 08:30

Sebastian Kobold
MD
Professor of experimental immune-oncology, Deputy Director of the Department of Clinical Pharmacology, LMU University Hospital, LMU Munich

Immunotherapy of cancer – from bench to bedside
Thursday, Sep 12th, 18:00

Maximilian F. Konig
MD
Assistant Professor of Medicine, Rheumatology, Johns Hopkins University,
Baltimore, MD, USA



Avoiding collateral damage: precision immuno-therapy for autoimmunity and cancer
Friday, Sep 13th, 17:00

Antigen-specific therapies for anti-phospholipid syndrome
Saturday, Sep 14th, 12:00

Andreas Mackensen
MD
Professor of Medicine, Medical Clinic 5, Hematology and internal Oncology, University Hospital Erlangen

CAR-T cell therapy for autoimmune disease
Saturday, Sep 14th, 09:30

Tobias Peikert
MD
Associate Professor of Medicine, Consultant Pulmonary & Critical Care, Mayo Clinic,
Rochester, MN, USA
(Chair)


Lung cancer therapy in the age of immunotherapy
Friday, Sep 13th, 10:40

Immunotherapy for mesothelioma
Friday, Sep 13th, 11:40

Sanjeev Sethi
MD, PhD
Professor of Laboratory Medicine and Pathology, Consultant Renal Pathology, Mayo Clinic,
Rochester, MN, USA
(Chair)

Mapping the antigens of membranous nephropathy
Friday, Sep 13th, 09:00

C3 Glomerulopathy: what is new?
Friday, Sep 13th, 14:10

Ulrich Specks
MD
Professor of Medicine, Consultant Pulmonary & Critical Care, Mayo Clinic, Rochester, MN, USA (Chair)





Welcome and introduction
Thursday, Sep 12th, 15:30

ANCA-associated vasculitis: from pathogenesis to targeted therapy
Thursday, Sep 12th, 15:45

Wrap up and Farewell
Saturday, Sep 14th, 12:30

Christine Spitzweg
MD
Professor of Medicine,
Division of Endocrinology, Medical Clinic IV,
LMU University Hospital,
LMU Munich
(Chair)


Chair:
Immunotherapy – from Vision to Standard of Care
Friday, Sep 13th, 10:40

Michael Staehler
MD
Professor of Medicine, Senior Physician at the Urological Clinic and Polyclinic, LMU University Hospital, LMU Munich

Immune-checkpoint inhibitor therapy in renal cell carcinoma
Friday, Sep 13th, 11:10

Louise Füeßl
MD
Medical Clinic IV,
LMU University Hospital,
LMU Munich

Case Session
Friday, Sep 13th, 16:00

Ulf Schönermarck
MD
Senior physician at the Nephrology Center, Medical Clinic IV, LMU University Hospital,
LMU Munich (Chair)

Chair: From bench to bedside
Saturday, Sep 14th, 11:00

Anke von Bergwelt-Baildon
MD

Senior physician at the Nephrology Center,
Medical Clinic IV,
LMU University Hospital,
LMU Munich

Volker Vielhauer
MD
Professor of Medicine,
Senior physician at the
Nephrology Center,
Medical Clinic IV,
LMU University Hospital,
LMU Munich

Chair: Novel Classification in Kidney Disease Impacts Management
Friday, Sep 13th, 08:30

Mariam P. Alexander
MD
Professor of Laboratory Medicine & Pathology, Consultant Renal Pathology, Mayo Clinic,
Rochester, MN, USA

Pathology of immune-checkpoint inhibitor therapy
Friday, Sep 13th, 10:00

Renal pathology in monoclonal gammopathy
Friday, Sep 13th, 16:30

Philippe R. Bauer
MD, PhD
Professor of Medicine,
Consultant Pulmonary & Critical Care, Mayo Clinic,
Rochester, MN, USA



ICU management of hemato-oncologic therapy complications
Friday, Sep 13th, 12:40

Critical care of immunocompromised patients
Friday, Sep 13th, 17:30

Jürgen Behr
MD

Professor of Medicine, Director Medical Clinic V - Pulmunology, LMU University Hospital,
LMU Munich

Lung transplantation in patients with pulmonary hypertension
Thursday, Sep 12th, 17:30

Michael von Bergwelt
MD,PhD
Professor of Medicine,
Director Medical Clinic III,
Hematology and Oncology,
LMU University Hospital, LMU Munich (Chair)

Welcome and introduction
Thursday, Sep 12th, 15:30

Wrap up and Farewell
Saturday, Sep 14th, 12:30

Veit Bücklein
MD

Attending Hematologist-Oncologist at the Medical Clinic III
Hematology and Oncology LMU University Hospital,
LMU Munich

CAR-T cell therapy in hemato-oncology
Saturday, Sep 14th, 09:00

Case Session
Saturday, Sep 14th, 11:00

Ali Duarte Garcia
MD
Assistant Professor of Medicine, Consultant Rheumatology, Mayo Clinic,
Rochester, MN, USA





Lupus nephritis – current and future treatment options
Friday, Sep 13th, 14:30

APS reclassified: understanding the new criteria
and the clinical impact
Saturday, Sep 14th, 11:30

Hilary M. DuBrock
MD
Associate Professor of Medicine, Consultant Pulmonary & Critical Care, Mayo Clinic,
Rochester, MN, USA

Pulmonary hypertension associated with myeloproliferative and kidney disease
Thursday, Sep 12th, 16:15

Fernando C. Fervenza
MD,PhD
Professor of Medicine, Consultant Nephrology & Hypertension, Mayo Clinic,
Rochester, MN, USA



Management of membranous nephropathy
Friday, Sep 13th, 09:40

Primary, secondary and genetic forms of FSGS: a clinical approach
Friday, Sep 13th, 15:00

Tobias Feuchtinger
MD

Professor of Medicine, Professor of Medicine, Director Pediatric, Hematology and Oncology,
University Hospital Freiburg

Cell therapy in infectious disease
Saturday, Sep 14th, 10:00

Michael Fischereder
MD
Professor of Medicine, Head of the Nephrology Center, Medical Clinic IV, LMU University Hospital,
LMU Munich (Chair)

Welcome and introduction
Thursday, Sep 12th, 15:30

Wrap up and Farewell
Saturday, Sep 14th, 12:30

Jürgen Floege
MD
Professor of Medicine,
Director emeritus of the Medical Clinic II – Kidney and Hypertension Diseases,
University Hospital of RWTH Aachen

IgA nephropathy – how to treat in the future?
Friday, Sep 13th, 08:30

Sebastian Kobold
MD
Professor of experimental immune-oncology, Deputy Director of the Department of Clinical Pharmacology, LMU University Hospital, LMU Munich

Immunotherapy of cancer – from bench to bedside
Thursday, Sep 12th, 18:00

Maximilian F. Konig
MD
Assistant Professor of Medicine, Rheumatology, Johns Hopkins University,
Baltimore, MD, USA





Avoiding collateral damage: precision immuno-therapy for autoimmunity and cancer
Friday, Sep 13th, 17:00

Antigen-specific therapies for anti-phospholipid syndrome
Saturday, Sep 14th, 12:00

Andreas Mackensen
MD
Professor of Medicine, Medical Clinic 5, Hematology and internal Oncology, University Hospital Erlangen

CAR-T cell therapy for autoimmune disease
Saturday, Sep 14th, 09:30

Tobias Peikert
MD
Associate Professor of Medicine, Consultant Pulmonary & Critical Care, Mayo Clinic,
Rochester, MN, USA



Lung cancer therapy in the age of immunotherapy
Friday, Sep 13th, 10:40

Immunotherapy for mesothelioma
Friday, Sep 13th, 11:40

Sanjeev Sethi
MD, PhD

Professor of Laboratory Medicine and Pathology, Consultant Renal Pathology, Mayo Clinic,
Rochester, MN, USA



Mapping the antigens of membranous nephropathy
Friday, Sep 13th, 09:00

C3 Glomerulopathy: what is new?
Friday, Sep 13th, 14:10

Ulrich Specks
MD
Professor of Medicine, Consultant Pulmonary & Critical Care, Mayo Clinic, Rochester, MN, USA (Chair)








Welcome and introduction
Thursday, Sep 12th, 15:30

ANCA-associated vasculitis: from pathogenesis to targeted therapy
Thursday, Sep 12th, 15:45

Wrap up and Farewell
Saturday, Sep 14th, 12:30

Michael Staehler
MD
Professor of Medicine, Senior Physician at the Urological Clinic and Polyclinic, LMU University Hospital, LMU Munich

Immune-checkpoint inhibitor therapy in renal cell carcinoma
Friday, Sep 13th, 11:10

Christine Spitzweg
MD
Professor of Medicine,
Division of Endocrinology, Medical Clinic IV,
LMU University Hospital,
LMU Munich
(Chair)


Chair: Immunotherapy – from Vision to Standard of Care
Friday, Sep 13th, 10:40

Clemens Cohen
MD
Professor of Medicine,
Head Department for Nephrology, München Klinik gGmbH
(Chair)

Chair: Dealing with Complications of Novel Therapy
Friday, Sep 13th, 14:10

Louise Füeßl
MD

Medical Clinic IV,
LMU University Hospital,
LMU Munich

Case Session
Friday, Sep 13th, 16:00

Ulf Schönermarck
MD
Senior physician at the Nephrology Center, Medical Clinic IV, LMU University Hospital,
LMU Munich (Chair)

Chair: From bench to bedside
Saturday, Sep 14th, 11:00

Anke von Bergwelt-Baildon
MD

Senior physician at the Nephrology Center,
Medical Clinic IV,
LMU University Hospital,
LMU Munich

Volker Vielhauer
MD
Professor of Medicine,
Senior physician at the
Nephrology Center,
Medical Clinic IV,
LMU University Hospital,
LMU Munich

Chair: Novel Classification in Kidney Disease Impacts Management
Friday, Sep 13th, 08:30